NCT00402805View on ClinicalTrials.gov

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

July 31, 2007

Conditions
Lung TransplantationInfluenza Vaccines
Interventions
BIOLOGICAL

Trivalent Inactivated Influenza Vaccine

Trial Locations (1)

M5G 2N2

Multi-Organ Transplant Program, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT00402805 - Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy | Biotech Hunter | Biotech Hunter